Edinburgh-based biotech firm OGI Bio has beaten off competition from nine local tech startups to be crowned Scotland’s Tech Innovator 2024 in KPMG’s UK-wide competition.
Edinburgh-based biotech firm OGI Bio has secured follow-on funding of £650,000 in a deal led by TRICAPITAL Angels and supported by Scottish Enterprise, Merleview, Apollo, and Old College Capital.
Robertson Construction Central East has successfully delivered the £12 million 4D Cellular Medicine Building that will support cancer and health research for the University of Edinburgh.
This week, Glasgow-based Global PR & creative agency Smarts was recognised in three categories within PR Week’s esteemed Top 150 rankings; named the largest agency outside of London, 30th largest agency in the UK overall, and the 4th largest consumer agency.
Glasgow-headquartered clinical research facility, NeuroClin, has appointed Fiona Wood as its new CEO and confirmed an agreement has been reached to open a new site in North West England this Autumn.
The Sustainable Aquaculture Innovation Centre (SAIC) has secured new funding to continue its support of fish health research and development (R&D), delivered in collaboration between the private and public sectors.
Nebu-Flow, a University of Glasgow spinout developing next-generation inhaled drugs for respiratory disorders, has secured an additional £4.7 million investment.
Phlo has announced the close of a £9 million funding round, accessing additional investment for their group of businesses amid a challenging investor market.
Scottish biopharmaceutical firm EnteroBiotix has raised over £27 million from new and existing investors, positioning it to expand and accelerate its pioneering work in developing microbiome medicines.
Scottish-based PhaSER Biomedical (PhaSER) has agreed a long-term partnership with the Sanders Tri-Institutional Therapeutic Discovery Institute, Inc. (TDI) to enhance the institute’s groundbreaking pre-clinical drug discovery research.
Scotland’s thriving life sciences sector needs increased investment in top-quality lab and research facilities to sustain growth, according to real estate advisor CBRE.